Vascular medicine plays a key role in understanding the cardiovascular specifics of women, often underestimated in the past. Recent research highlights significant differences in how vascular diseases affect women compared to men, particularly in terms of symptoms, risks and responses to treatment. For example, women are more likely to present atypical symptoms of myocardial infarction, such as intense fatigue or back pain, which can delay diagnosis and treatment.
Moreover, women experience hormonal fluctuations throughout their lives, particularly during pregnancy and menopause, that can influence vascular health. These periods are associated with changes in oestrogen levels, affecting stiffness and function of blood vessels. This can increase the risk of developing vascular diseases such as hypertension and atherosclerosis.
Thus, vascular medicine in women is not limited to treating diseases — it extends to a preventive approach that integrates monitoring of hormonal factors, education on women-specific symptoms, and tailored risk management strategies. This integrated approach is vital to improve health outcomes for women and to promote equitable and effective management of cardiovascular diseases.

How does diabetes progress? It is an epidemic that is spreading rapidly around the world, alongside obesity, and France is no exception. According to the French national health insurance system, there are 3.8 million diabetics in our country. However, many sufferers are unaware of their condition, as [...]

Agir pour le Coeur des Femmes is pleased to take part in a conference dedicated to lipoedema that will be organized at the end of the summer in New Caledonia. Practical information: Southern Province Auditorium - Wednesday, August 27, 2025 - 6pm to 8pm (welcome from 5:45pm) Free event - Open to [...]

An aneurysm is defined as an increase in the size (diameter) of an artery of more than 50% compared with the normal value: if the normal value is 20 mm, the anomaly starts at 30 mm. Aneurysms can be located in any artery, with particular attention paid to the aorta (the largest artery) in the [...]

Venous thrombo-embolic disease (VTE) is an important part of vascular medicine, and has 2 aspects: Venous thrombosis, commonly known as "phlebitis", which corresponds to the obstruction of a vein by a clot, and the migration of this clot into the pulmonary circulation, which represents the serious [...]
-un-nouveau-marqueur-de-risque-cardio-vasculaire-405-portrait.jpeg)
The classic lipid panel measures total cholesterol, triglycerides and high-density lipoprotein (HDL) cholesterol. Then low-density lipoprotein (LDL) cholesterol is calculated, which is strongly linked to the risk of coronary heart disease and stroke, and does not include measurement of lipoprotein(a) [...]
-ou-AOMI-390-portrait.jpeg)
Why a scientific statement? In the United States, 8.5 million people have peripheral arterial disease (PAD), which we more commonly refer to as Obliterative Arterial Disease of the Lower Limbs (AOMI), corresponding to narrowing or obstruction of the arteries of the legs by atherosclerotic plaques. [...]

The US Prevention Services Task Force (USPSTF) has just reiterated its previous recommendations, dating from 2016, for individuals between the ages of 40 and 75, with no known CVD or history of familial hypercholesterolemia, and with LDL cholesterol (LDL-C or bad cholesterol) below 1.9 g/L: - There [...]

What is familial hypercholesterolemia? Familial hypercholesterolemia is an autosomal dominant genetic disease, meaning that a patient has a 50/50 chance of passing the disease on to his or her child. For each gene, we inherit one allele (=version) from our mother and another from our father. This is [...]